🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06664190
Active, not recruiting Observational

Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency

NCT06664190 · tracked via the Priya Life Science China tracker
Sponsor
Huashan Hospital
Phase
Observational
Started
2022-08-01
Last updated
2024-10-29

Condition(s) studied

Pituitary Adenoma

Investigational drug(s) / intervention(s)

Advanced sequences, such as arterial spin labeling (ASL) and diffusion-weighted imaging (DWI)

Advanced sequences, such as arterial spin labeling (ASL) and diffusion-weighted imaging (DWI): Advanced sequences, such as arterial spin labeling (ASL) and diffusion-weighted imaging (DWI)

Study summary

Pituitary adenomas (PAs) are among the most prevalent lesions of the sella turcica, accounting for 10%-25% of all intracranial neoplasms. Pituitary macroadenomas (PMAs) are defined with a maximum diameter of over 1 cm. Tumor characteristics are key factors influencing surgical effectiveness and complications of PMAs, with tumor perfusion and consistency identified as major predictive factors in literature. Conventional sequences provide limited information for predicting the perfusion and consistency of pituitary adenomas. Advanced sequences offer additional insights. However, the efficacy of combining radiomic features from multiparametric sequences, incorporating both conventional and advanced sequences, has not yet been proved.

We aim to develop machine learning models that combines radiomic features developed from both conventional and advanced sequences to predict the perfusion and consistency of PMAs. Furthermore, we aim to demonstrate the clinically applicability of these models by constructing a MR-PIT stratification (Multiparametric Radiomic derived and tumor Perfusion and consIsTency based surgical difficulty stratification), which correlated with the surgical strategy and outcomes.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * patients with tumor more than 2.5 cm of maximal diameter in the coronal plane * Functional and non-functional pituitary tumors Exclusion Criteria: * incomplete image data

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Huashan Hospital Shanghai Shanghai Municipality

More Huashan Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06664190 on ClinicalTrials.gov ↗ ← All trials in China